Soho Flordis International signs an agreement for the acquisition of Potters and the Equazen(TM) brand portfolio from Vifor Pharma
(Thomson Reuters ONE) -
Vifor Pharma Ltd. /
Soho Flordis International signs an agreement for the acquisition of Potters and
the Equazen(TM) brand portfolio from Vifor Pharma
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Soho Flordis International (SFI), through its Swiss subsidiary Ginsana SA, will
acquire leading UK manufacturer and supplier of traditional herbal treatments
Potters, from Vifor Pharma, a company of the Galenica Group.
Potters, based in Wigan, England, has more than 200 years of history as a
producer of high quality herbal-based treatments and is the oldest herbal
medicine company in the United Kingdom. Its extensive range of well-established
products includes treatments for coughs and colds, pain and joint care, gastro-
intestinal disorders and women's health. In addition to this range of products,
Potters features brands like Red Kooga(®), Seatone(®), Calcia(TM) as well as
Equazen(TM), one of the world's leading fish oil containing health products.
The Equazen(TM) brand is backed by robust specific clinical research and in
recent years has expanded to deliver brain health solutions to various patient
groups. The brand also includes the international product Equazen(TM) eye-q(TM).
Potters products are sold throughout the UK by leading retailers such as Boots
and Holland & Barrett as well as pharmacy and health food outlets.
With subsidiary companies in Europe, Asia and America, the SFI Group draws on
more than 70 years of international experience in the high-quality natural
health sector. The SFI Group is committed to providing clinically proven natural
health solutions to health professionals and consumers worldwide.
Vifor Pharma is a global leader in the treatment of iron deficiency. Vifor
Pharma has decided to focus its resources and efforts on maximising and
expanding its portfolio of specialty pharmaceuticals as it prepares for life as
a stand-alone company.
Nigel Pollard, CEO of SFI, commented: "Potters is a strong and iconic brand in
the natural medicine sector. Together with its history of over two centuries,
Potters will bring to the SFI Group an excellent team and an extensive portfolio
of trusted products. These products and the business platform in the UK and
Europe are an excellent fit for SFI as we seek to build our world leading
position in the field of clinically-proven natural medicine."
The transaction is expected to be completed in the fourth quarter of 2015.
Financial details of the transaction were not disclosed.
For further information, please contact:
Media Relations - SFI:
Elisa Ranieri, Head of Marketing EMEA
Tel.: +41 91 610 3724
E-mail: ranieri(at)ginsana.ch
Media Relations - Vifor Pharma:
Beatrix Benz, Head of Global Communications
Tel.: +41 58 851 80 16
E-mail: media(at)viforpharma.com
Vifor Pharma, a company of the Galenica Group, is a world leader in the
discovery, development, manufacturing and marketing of pharmaceutical products
for the treatment of iron deficiency. The company also offers a diversified
portfolio of prescription medicines as well as over-the-counter (OTC) products.
Vifor Pharma, headquartered in Zurich, Switzerland, has an increasingly global
presence and a broad network of affiliates and partners around the world.
For more information about Vifor Pharma and its parent company Galenica, please
visit www.viforpharma.com and www.galenica.com
Soho Flordis International (SFI), an Australian registered company, is an
international provider of clinically proven natural medicines. SFI is committed
to identifying and developing leading natural medicines with the best evidence
of effectiveness, quality and safety, and marketing them around the world
through healthcare professionals with the endorsement of world class opinion
leaders.
For more information about SFI, please visit www.sfihealth.com
Equazen(TM) eye q(TM )is a dietary supplement with a specific combination of
omega-3 and omega-6 fatty acids from natural sources (fish oil and evening
primrose oil). Equazen(TM) eye q(TM )unique formulation has been tested in
clinical trials and showed efficacy in brain function, particularly in children
and adolescents with learning disabilities, cognitive & developmental disorders
such as dyslexia, dyspraxia, or ADHD-symptoms(1,2,3,4).
For more information about Equazen(TM) eye q(TM )please visit www.EQUAZEN.com
1. M. Johnson, S. Östlund, G. Fransson, B. Kadesjö, C.Gillberg,Omega-3/omega-6
fatty acids for attention deficit hyperactivity disorder, J. Atten. Disord.
12 (2008)394-401.
2. A.J. Richardson, P. Montgomery, The Oxford-Durham study: a randomised,
controlled trial of dietary supplementation with fatty acids in children
with developmental coordination disorder, Pediatrics 115(2005)1360-1366.
3. N. Sinn, J. Bryan, Effect of supplementation with polyunsaturated fatty
acids and micronutrients on ADHD-related problems with attention and
behavior, J. Dev. Behav. Pediatr. 28(2007)82-91.
4. N. Sinn, J. Bryan, C. Wilson, Cognitive effects of polyunsaturated fatty
acids in children with attention deficit hyperactivity disorder symptoms: a
randomised controlled trial, Prostaglandins Leukot. Essent.FattyAcids78
(2008)311-326.
For information about Potters, please visit: www.pottersherbals.co.uk
Press Release (PDF):
http://hugin.info/148637/R/1960634/714762.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Vifor Pharma Ltd. via GlobeNewswire
[HUG#1960634]
Datum: 22.10.2015 - 07:19 Uhr
Sprache: Deutsch
News-ID 428658
Anzahl Zeichen: 6654
contact information:
Town:
Glattbrugg
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 340 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Soho Flordis International signs an agreement for the acquisition of Potters and the Equazen(TM) brand portfolio from Vifor Pharma"
steht unter der journalistisch-redaktionellen Verantwortung von
Vifor Pharma Ltd. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
